🇺🇸 FDA
Patent

US 8618134

Method and composition for treating a serotonin receptor-mediated condition

granted A61KA61K31/445A61K31/454

Quick answer

US patent 8618134 (Method and composition for treating a serotonin receptor-mediated condition) held by VANDA PHARMACEUTICALS INC. expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/445, A61K31/454, A61K45/06, A61P